The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis

BACKGROUND: The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), demonstrated its effectiveness for lowering serum phosphate levels, with low daily pill burden, in clinical trials of dialysis patients with hyperphosphatemia. This retrospective database analysis evaluated the real-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Rosa, Chazot, Charles, Ferreira, Anibal, Di Benedetto, Attilio, Gurevich, Konstantin, Feuersenger, Astrid, Wolf, Melanie, Arens, Hans-Jürgen, Walpen, Sebastian, Stuard, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720479/
https://www.ncbi.nlm.nih.gov/pubmed/33287733
http://dx.doi.org/10.1186/s12882-020-02188-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720479/
https://www.ncbi.nlm.nih.gov/pubmed/33287733
http://dx.doi.org/10.1186/s12882-020-02188-8

Ejemplares similares